Matt McGee is a counsel in the firm’s Litigation practice. His practice focuses on the representation of companies and their directors and officers in complex business litigation, class action defense, shareholder derivative suits, securities fraud class actions and M&A litigation. Matt has successfully represented his clients in numerous matters, including a victory on behalf of an alleged controlling majority group of shareholders in the United States Court of Appeals for the Fifth Circuit.

• Defense of putative federal Securities Act class action in Texas state court. Defending an international chemical manufacturer against a putative class action pending in Texas state court alleging violations of the federal Securities Act of 1933 in connection with two public stock offerings.
• Won dismissal with prejudice in District Court and affirmance by Fifth Circuit on alleged improper equity dilution and minority shareholder oppression claims under Delaware law, arising from the sale of Ascension Orthopedics to Integra Life Sciences, representing alleged controlling majority shareholders. Joe W. and Dorothy Dorsett Brown Foundation v. Frazier Healthcare V, L.P., 2012 WL 3834029 (W.D. Tex., Aug. 27, 2012), aff’d, No. 12-51012 (5th Cir. Aug. 12, 2013).
• Defeated class certification for the National Football League in lawsuit alleging claims of breach of contract and fraud against the NFL and the Dallas Cowboys for allegedly not providing prescribed seats to ticketholders at the Super Bowl XLV game.
• Represented Lextron, Inc. in connection with the successful acquisition of Animal Health International, Inc., and five shareholder class actions filed in Delaware and Texas state courts, alleging breaches of fiduciary duties by the target’s directors, and purported aiding and abetting by the acquiror.
• Represented Cerberus Capital Management and its affiliates in connection with the successful acquisition of Silverleaf, a Texas corporation, and related state court derivative litigation alleging breaches of fiduciary duties by the target’s directors, and purported aiding and abetting by the acquiror.
• Defended publicly-traded natural gas and oil company in SEC investigation of reserve accounting and related public disclosures; Received termination letter indicating no action would be recommended by SEC staff.
• Won summary dismissal with prejudice of False Claims Act suit against defense contractor client. (N.D. Tex. 2012).